Guochun Liao

Guochun is a serial entrepreneur enthusiastic about pushing the boundaries of combining the power of computer and data sciences with life sciences to provide solutions for the biggest challenges in healthcare. 20+ years of proven experience in leading and managing multi-discipline teams in large pharmaceutical and small biotechnology startup companies. Some of his early work was featured on the cover of the Journal of Science and Genome Research. With the belief that the convergence of technology and biology will redefine the biotechnology industry and accelerate a paradigm shift in medicine, he founded IDbyDNA (Acquired by Illumina on June 2022) and raised over $65M as CEO to make NGS metagnomics-based infectious disease testing from concept to reality.